EUVIMEDSkopri EUVIMED
Crossref

In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment

Alberto Ferrarese, Paola Zanaga, Sara Battistella, Silvia Zanella, Teresa Zappitelli, Caterina Boldrin, Monia Pacenti, Margherita Cattai, Greta Bordignon, Federica Gomiero, Magdalena Epifani, Marco Villano and 17 more

Alimentary Pharmacology & Therapeutics · 2025-02 · 61 (4) · 667-674

DOI: 10.1111/apt.18433 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2024-12-10. Written by Alberto Ferrarese and 28 co-authors. Institution: Gastroenterology and Multivisceral Transplant Unit, Padua University Hospital, Padua, Italy. Major MEDLINE topics: Mass Screening, Hepatitis C. Cited 5 times so far (Crossref); 24 references. Funded by: This research was funded by the Consorzio per la Ricerca Sanitaria (CORIS)- Veneto Region, within the 2019 "Call for public-private collaboration on the submis…, Consorzio per la Ricerca Sanitaria.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Screening programmes for the detection of patients with hepatitis C virus (HCV) and positive viral load have been developed in many countries to achieve the World Health Organization's goal of HCV elimination by 2030. In Italy, a phased screening programme starting with individuals born between 1969 and 1989 has been implemented.

Aim

To assess the prevalence of patients with positive viraemia identified through a universal screening campaign conducted among hospitalised patients at our centre during the calendar year 2022.

Methods

All adult (aged ≥ 18 years) hospitalised patients, who participated in HCV screening from January to December 2022 were included, without any age restriction. Screening initially involved testing for anti‐HCV antibodies and then patients who tested positive underwent further HCV‐RNA testing.

Results

A total of 10,846 samples were collected. Five hundred and thirty cases (4.8%) tested positive for HCV antibodies, and 109 (1%) tested positive for both HCV antibodies and HCV‐RNA. Among patients with a positive viral load, the median [IQR] age was 62 [53–77] years, with a significant age difference between males and females (59 [48–67] vs. 78 [62–88]; Mann–Whitney U ‐test, p = 0.001). Eighty‐four (77%) patients with a positive viral load were outside the target age range specified in the current National Recommendations for free‐of‐charge screening.

Conclusions

The non‐negligible prevalence of patients with a positive viral load among an unselected group of hospitalised patients suggests that such settings could effectively enhance screening programmes aimed at HCV elimination. Additionally, this approach may help identify patients who are not currently included in the National Recommendations.

Subjects

MeSH terms (MEDLINE)

Mass ScreeningHepatitis CHumansMaleFemaleMiddle AgedAgedItalyHepatitis C AntibodiesViral LoadAged, 80 and overPrevalenceRNA, ViralHepacivirusAdultHospitalization

Author keywords

1969–1989 birth cohortdirect‐acting antiviral agentssustained virological response

Substances

Hepatitis C AntibodiesRNA, Viral

Authors and institutions

  • Gastroenterology and Multivisceral Transplant Unit, Padua University Hospital, Padua, Italy.
  • Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
  • Microbiology Unit, Padua University Hospital, Padua, Italy.
  • Direzione Medica Ospedaliera, Padua University Hospital, Padua, Italy.
  • Information Technology System Unit, Padua University Hospital, Padua, Italy.
  • Unit of Internal Medicine and Hepatology Unit, Department of Medicine, Padua University Hospital, Padua, Italy.

ORCID profiles: Nora Cazzagon, Lorenzo Calò, Francesco Paolo Russo

Funding

  • This research was funded by the Consorzio per la Ricerca Sanitaria (CORIS)- Veneto Region, within the 2019 "Call for public-private collaboration on the submis…
  • Consorzio per la Ricerca Sanitaria

Cite

APA

Ferrarese, A., Zanaga, P., Battistella, S., Zanella, S., Zappitelli, T., Boldrin, C., Pacenti, M., Cattai, M., Bordignon, G., Gomiero, F., Epifani, M., Villano, M., Gambato, M., Zanetto, A., Cazzagon, N., Chemello, L., Pasin, F., Calò, L., Doria, A., …, & Russo, F. P. (2025). In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment. Alimentary Pharmacology & Therapeutics, 61(4), 667-674. https://doi.org/10.1111/apt.18433

Vancouver

Ferrarese A, Zanaga P, Battistella S, Zanella S, Zappitelli T, Boldrin C, et al. In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment. Alimentary Pharmacology & Therapeutics. 2025;61(4):667-674. doi:10.1111/apt.18433

BibTeX
@article{Ferrarese2025,
  author = {Ferrarese, Alberto and Zanaga, Paola and Battistella, Sara and Zanella, Silvia and Zappitelli, Teresa and Boldrin, Caterina and Pacenti, Monia and Cattai, Margherita and Bordignon, Greta and Gomiero, Federica and Epifani, Magdalena and Villano, Marco and Gambato, Martina and Zanetto, Alberto and Cazzagon, Nora and Chemello, Liliana and Pasin, Francesca and Calò, Lorenzo and Doria, Andrea and Trentin, Livio and Illiceto, Sabino and Avogaro, Angelo and Venturini, Francesca and Simioni, Paolo and Angeli, Paolo and Tessarin, Michele and Burra, Patrizia and Cattelan, Annamaria and Russo, Francesco Paolo},
  title = {In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  volume = {61},
  number = {4},
  pages = {667--674},
  doi = {10.1111/apt.18433}
}
Start for free →